Filing Details

Accession Number:
0001209191-17-023485
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-29 16:09:10
Reporting Period:
2017-03-28
Filing Date:
2017-03-29
Accepted Time:
2017-03-29 16:09:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629794 New Enterprise Associates 15, L.p. 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1640031 Nea Partners 15, L.p. 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1640033 Nea 15 Gp, Llc 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1644965 Growth Equity Opportunities Iv, Llc 1954 Greenspring Drive, Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-28 6,000,000 $0.50 16,362,694 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reports the purchase of shares in the underwritten public offering of common stock of AVEO Pharmaceuticals, Inc.
  2. The shares are directly held by Growth Equity Opportunities Fund IV, LLC ("GEO IV") and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP, together, the "Indirect Reporting Persons"). The individual managers of NEA 15 GP are Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Josh Makower, David M. Mott, Jon Sakoda, Scott D. Sandell, Peter W. Sonsini and Ravi Viswanathan. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by GEO IV in which the Indirect Reporting Persons have no pecuniary interest.